News and Information

Biofourmis Names Two Pharmaceutical Veterans to Leadership Team

BOSTON, Aug. 22, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, has added two global pharmaceutical senior executive veterans to its executive team to guide the company’s worldwide expansion across the pharmaceutical, managed care, healthcare provider and medical technology markets.

Read More

Biofourmis in the Beckers’ List of Top 100 AI Companies to Know in Healthcare

Biofourmis offers a powerful patented AI-based platform for therapeutic decision support. It continuously analyzes data from medical-grade wearable sensors and other patient-generated data to create unique digital biomarkers reflecting the health status of an individual. These digital biomarkers have been assessed in several studies and have demonstrated the ability to help detect changes in an individual’s health status much earlier than previously possible.

Read More
View More


Biofourmis Presented 4 Peer-reviewed Papers at The International Engineering in Medicine and Biology Conference

Our data scientist team had recently presented 4 peer-reviewed papers demonstrating clinical effectiveness of #biovitals platform at the International Engineering in1.

Read More

Specialized Analytics to Support Clinical Trial Endpoints

We will be sharing on the topic “Specialized Analytics to Support Clinical Trial Endpoints”

Read More

Tackling health problems using AI: Why data analytics will play a big role in healthcare.

Our COO Karen Wai will be speaking at Echelon Asia Summit 2018 on the Topic: “Tackling health problems using AI: Why data analytics will play a big role in healthcare.”

Read More

What Our Clients Say

Whether you are a healthcare provider,
payer or pharmaceutical,
biofourmis empowers you

Get In Touch